What's breaking now, across thousands of outlets.
A Novo Nordisk drug missed the mark in a heart disease study, raising questions about targeting inflammation to prevent cardiovascular complications.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
The new CDC director nominee moves to the full Senate vote, Medicaid work requirements will not be delayed, and more health news
A gene involved in the brain’s overnight cleaning system may change how strongly poor sleep affects Alzheimer’s-related brain changes.
A gene involved in the brain’s overnight cleaning system may change how strongly poor sleep affects Alzheimer’s-related brain changes.
Surgery that aims to enhance the clearance of Alzheimer's-associated proteins from the brain has been banned in China, but only after thousands of people had the procedure
(MedPage Today) -- Oral ralinepag is positioned for potential FDA approval following its strong results as a treatment for pulmonary arterial hypertension (PAH) in an international phase III trial.
Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry. The post Merck after Keytruda: what the pipeline looks like appeared first on…
